fda warning compounded semaglutide safety 2024 2025 The has received reports of adverse events after patients used versions of semaglutide. Some compounders may also be using unapproved salt forms. Patients should avoid compounded when an FDA-approved The FDA has received reports

Using sophisticated research methods to study the way biology and behavior impact each other during GLP-1 therapy will help us to understand mechanisms that lead to the variable experiences people have on these medications with respect to weight, quality of life, substance use and others. The researchers hope the project will demonstrate the strength of collaboration across institutions and research settings, including two major research hubs within the Sanford Health System in Fargo and Sioux Falls, NDSU, and the Center for Advancement in Pharmacy at NDSU

Avoid Alcohol While an occasional drink may be fine for some, alcohol can pose challenges when taking GLP-1 medications

Your healthcare team can assess fit

Extended Data Figure 2 GLP-1R interhelical interaction network